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A B S T R A CT  
Human history has witnessed various pandemics throughout, and these cause disastrous effects on 
human health and country’s economy. Once again, after SARS (Severe Acute Respiratory Syndrome) 
and MERS (Middle East Respiratory Syndrome), the world is observing a very tough time fighting an 
invisible enemy, the novel COVID-19 coronavirus. Initially observed in the Wuhan province of China, 
now, it has spread across 210 countries. Number of corona affected confirmed cases have reached > 
3 million globally and death toll has reached to 258,481 as on 6th May,2020. Researchers are working 
round the clock, forming collaborative efforts and sharing their data to come up with a cure for this 
disease. The new coronavirus genome was quickly sequenced and clinical and epidemiological data are 
continuously being collected and analyzed. This data is crucial for forming better public health policies 
and developing antiviral drugs and vaccines. As there is no vaccine available in market against COVID-
19, personal health, immunity, social distancing and basic protection measures are extremely important. 
It is critical to avoid the virus infection and to strengthen the immune system as the coronavirus can 
be fatal for those with weak immunity.  This article reviews the nutritional and therapeutic potential of 
Spirulina, which is considered as superfood and a natural supplement to strengthen the immune system. 
Spirulina is highly nutritious and has hypolipidemic, hypoglycemic and antihypertensive properties. 
Spirulina contains several bioactive compounds, such as phenols, phycobiliproteins and sulphated 
polysaccharides and many more with proven antioxidant, anti-inflammatory and immunostimulant/ 
immunomodulatory effects. 
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1 Introduction 
Currently, SARS-CoV-2 or COVID-19, the causative pathogen of Coronavirus Disease   is rapidly 
spreading across the world. The virus is zoonotic in origin and was transmitted to humans through yet 
unknown intermediary animals (Zhou, P. et al., 2020). Coronavirus disease spreads primarily through 
contact with an infected person when they cough or sneeze (WHO, 2020). It also spreads when a person 
touches a contaminated surface or object and subsequently touches eyes, nose, or mouth. The disease causes 
respiratory illness with flu like symptoms such as a cough, cold, fever and difficulty in breathing. Many 
people can be asymptomatic carrier of this disease spreading infections in the society. Globally, the reported 
fatality rate is in range of 6.8 to 7% as on May 5, 2020 (WHO Situation Report-106; Max, R 2020). Most 
common diagnostics methods at present are RT-PCR test and antibody testing. However, for early 
detection serological tests kits are also being developed. To date, there is no fool proof vaccine have been 
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developed against this disease. Therefore, alternate approaches are in practice to prevent transmission of 
COVID 19 such as, hand sanitization using alcohol-based hand rubs, washing hands with soap at least for 
20 seconds, use of face masks and face shields by health workers, social distancing, home quarantine etc. 
As there is no vaccine and definitive treatment available so far, many experts recommend alternative 
protection measures in form of strengthening the immune system by consuming immunity boosting 
food/drinks and taking essential vitamins such as Vitamin A, B, C to improve general health. (MOHFW, 
2020). Amongst various immunity boosters prescribed by experts, Spirulina, which is a type of seaweed, is 
the most mentioned as an effective natural immunity enhancer for prevention of any potential infections 
(Belay, A., 2002). This filamentous alga, occurs naturally in tropical and subtropical lakes with high pH 
(Habib et.al.,2008). Spirulina is currently being produced in more than 22 countries and used in over 77 
countries (Sasson, A., 1997). Its nutritional relevance is underlined by its adoption by the UN as the food 
of the future and by its use by NASA as part of its Astronauts’ diet. Spirulina is described as a “Super food” 
(Tadros, M.G. and Normal, A.I., 1988; Kelly et.al., 2011). This filamentous alga has been used as a source 
of protein and vitamin supplement in humans without any significant side-effects since long time (Admassu, 
H. et.al.,2015; FDA, 2003). Spirulina has a high protein content ranging up to 70%, it also contains several 
vitamins, like B12, provitamin A (β-carotenes), and minerals such as iron (Ciferri, O.,1985; Sánchez, M., 
et.al., 2003; Habib, M.A.B., et.al., 2008). It is also rich in phenolic acids, tocopherols and γ-linolenic acid 
(Dillon et. al., 1995). As Spirulina lacks cellulose in their cell walls, it can be easily digested (Dillon et. al., 
1995). Parry’s Spirulina is the only organic Spirulina in the world awarded with GRAS (Generally Recognized 
as Safe) status by United States Food and Drug Administration (USFDA) (Tarantino, 2003; Salazar et. al., 
1996; Chamorro et. al., 1997; Salazar et. al., 1998; Belay 2002; Parry E.I.D., 2014). This blue-green 
filamentous alga is relatively easy to cultivate but flourishes mainly in large outdoor ponds under optimum 
sunlight, pH and nutrient conditions. Currently, Spirulina can be found in health food stores and is sold 
mainly as a dietary supplement in the form of health drinks, protein bars, capsules and tablets (Spolaore, P., 
et.al.,2006). The aim of this review is to summarize the potential nutritional and therapeutic applications of 
Spirulina on human health in the context with current pandemic situation globally.  
2 Historical Background of Spirulina 
The term Spirulina remains in use is because of historical reasons (Vonshak, 1997). In sixteenth century, S. 
platensis was first isolated from Lake Texcoco by the Aztecs and they devised the term “tecuitlatl” for 
Spirulina (Habib M. et.al., 2011). Later, Dangeard befell upon the anembu tribe which had been harvesting 
the filamentous algae from Lake Chad in Africa (Abdulqader, G., 2000). In 1940s he coined the name 
“dihe” for S. platensis which had been used extensively in many food products such as bread, meals, and 
cakes. In 1964, Spirulina was analyzed chemically and taken up for research studies by botanists, 
microbiologists, and scientists to explore its biotechnological potential (Zarrouk, C., 1966; Vonshak. A., 
1997; Siva Kiran, R.R., 2015). Spirulina, a blue green alga refers to the dried biomass of Arthrospira platensis 
(Gershwin, and Belay, 2007). The two species of Arthrospira were classified as A. maxima and A. platensis in 
the genus Spirulina. It belongs to photosynthetic bacteria that cover the groups Cyanobacteria and 
Prochlorophyta. Scientifically, there is a distinction exists between Spirulina and the genus Arthrospira. 
Arthrospira species are free-floating, autotrophic, filamentous cyanobacteria characterized by multicellular 
and cylindrical trichrome in an open left-handed helix. Naurally, these are habitants of tropical and 
subtropical lakes, show proliferative growth in in presence of high pH and high carbonate and bicarbonate 
concentrations (Habib et. Al., 2008; Sili C., et.al., 2012).  A. platensis is generally found in Africa, Asia, and 
South America, whereas A. maxima is confined to Central America (Vonshak, 1997). Mostly, open raceway 
ponds with paddle wheels are being used for commercial production of Spirulina (Habib et. al., 2008).  
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3 Nutritional and Therapeutic Properties of Spirulina 
Spirulina is blue green microalgae, which is one of the oldest life forms on Earth (Ciferri, O.,1985). It is 
partly responsible for producing the oxygen in the planet's atmosphere billions of years ago and supported 
origin of life on earth.  Spirulina is declared world's first superfood, which has a diverse nutritional 
composition (Kelly et.al.,2011). The protein content of Spirulina is in range of 55 to 70% protein which is 
more than or equivalent to beef, chicken, and soybeans. It is also found to be a rich source of essential and 
non-essential amino acids, gamma-linolenic acid (GLA), carotenoids, linoleic acid, arachidonic acid, 
vitamins, iron, calcium, phosphorus, nucleic acids RNA & DNA, chlorophyll, and phycocyanin (Henrikson, 
R..,1994; Belay, A., 1997; Patel A., et.al.,2006; Parry E.I.D., 2014). Spirulina offers a wide range of health 
benefits almost immediately upon ingestion as it lacks cellulose in cell wall. It offers an instantaneous boost 
to one's energy, and helps in improving the endurance and in reducing fatigue (Baicus, C. and Baicus, A., 
2007) It is a natural immunity booster, and provides excellent support for the heart, liver, and kidneys. 
Spirulina is a natural detoxifier, oxygenates blood, and help in removal of body toxins, thus reducing the 
chances of illness (Stahl, W. and Sıed, H., 2005; Chew, B.P. and Park, J.S., 2004). Being a natural appetite 
suppressant it also improves digestive system. Babadzhanov et.al., in their study reported Spirulina having 
strong antioxidant as well as anti-inflammatory properties (Babadzhanov, A.S.et.al.,2004). It helps in 
maintaining the pH balance of the body, thereby reducing inflammation throughout the body without any 
side effects (Stahl, W. and Sıed, H.,2005; Chew, B.P. and Park, J.S., 2004; Rabadiya, B. and Patel, P., 2010). 
Therapeutic compounds present in Spirulina and their proven beneficial effects on human health have been 
presented in table 1. 
Table 1: Therapeutically important compounds in Spirulina and their applications 
Bioactive Compounds in Spirulina 




Immunity enhancer, Anticancer Cheng-Wu Z, et.al.,1994; Hayashi, 
K,et.al.,1996a; Hayashi, T, et.al., 
1996b 
Antiviral, Induces haematopoiesis 
2 Sulpholipids Antiviral Gustafson, K.,1989 
3 Beta-carotene 
Source of Vitamin A, Anticancer, 
Antioxidant 
Kapoor, R. and Mehta, U.,1993 




Treatment of Arthritis, Anticancer, 
Fat-metabolism 
Nichols, B. and Wood, B.,1986 





Antioxidant, Anticancer Reddy M.C.,et.al,2003 
Immunity booster, Detoxifier Cheng-Wu, Z., et.al.,1994; Patel, A., 
2006; Chen, J.C., et.al.,2012 Antiviral, Induces Haematopoiesis 
3.1 Antiviral Properties 
In many research studies, Spirulina has been reported to have strong antiviral activities.  It is established in 
various reports that at low dosages Spirulina results in inhibition in viral replication however, at higher 
concentrations it completely results in blocking replication (Hayashi, K., et.al.,1993; Hayashi, K., 
et.al.,1996a). In case of herpes simplex virus Type-1 (HSV-1), a water based extract of Spirulina has been 
found effective in inhibiting viral cell-penetration and replication in a dose-dependent manner (Hayashi, 
K., et.al.,1993; Hayashi, K., et.al.,1996b, Hernández-Corona, A., et.al., 2002). The Spirulina extract, without 
suppressing host cell functions, inhibits viral protein synthesis. The antiviral activity of Spirulina is attributed 
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to calcium –spirulan (Ca-Sp), which has been shown to inhibit replication of many viruses by inhibition of 
viral penetration into target cells without host toxicity (Deng et. al., 2011; Deng and Chow, 2010; Falquet, 
1997; Rhoades et. al., 1992). Researchers from National Cancer Institute (NCI), USA studied potential 
antiviral compounds extracts from blue green algae, including Spirulina platensis. The NCI research group 
found 60 various cyanobacteria culture to have the bioactive substances that caused significant antiviral 
effect by reducing cytopathic effects induced by viral infections (Patterson et. al., 1993). Acidic 
polysaccharides from Spirulina such as calcium spirulan (Ca-SP) are the potent virus inhibitors against 
several enveloped viruses (Hayashi, T., et.al.,1996). Highest antiviral activity was detected in S. maxima 
extracts prepared from methanol-water (3:1) (Hernández-Corona, et. al., 2002). The extracts of 
cyanobacteria in methanol contain sulfated polysaccharides which significantly prevents virus attachment 
to host cell. The inhibition of the fusion between uninfected CD4+ lymphocytes greatly enhances antiviral 
activity as this makes virus unable to take over host machinery. This stops the viral reproduction and 
multiplication (Feldmann et. al., 1999; Singh et. al., 2011). The extract does not kill the virus but interferes 
with the virus entry into host cells (Hayashi K., et. al., 1993). However, methanol (MeOH) and water 
extracts of Spirulina plantensis were significantly effective against adenovirus type 40 and reduces the infection 
50% and 23% respectively. The nontoxic concentrations for all the extracts were 2 mg/ml (Sayda et. 
al.,2012). The calcium spirulan (Ca-Sp) a sulfated polysaccharide isolated from Spirulina platensis inhibits 
many virus replications and exhibits broad-spectrum antiviral activity against the HSV-1, influenza virus, 
Human cytomegalovirus (HVMV), mumps virus, measles virus and human immunodeficiency virus type 1 
(HIV-1, HIV-2, and other series of enveloped viruses (Hayashi K., et. al., 1996; Simpore et. al., 2005; 
Feldmann et. al., 1999; Singh et. al., 2011). The inhibition of entry of Dengue virus by carbohydrate 
inhibitors was studied by Kazuya et. al. (2013). The study made by Gorobets et al. (2002) showed that the 
addition of S. platensis on bacteriophage T4 (bacterial virus) produced an inhibiting effect on the 
reproduction of the bacteriophage in Escherichia coli B cells. The purified pigment allophycocyanin of 
Spirulina platensis also exhibits antiviral activity and it neutralizes the cytopathic effects induced by Enterovirus 
71. The allophycocyanin pigment protein basically delays viral RNA synthesis and activates apoptosis in 
both human rhabdomyosarcoma cells and Afrin green monkey kidney cells (Shih et. al., 2003).  
3.2 Immunostimulant 
S. platensis which is primarily used as a dietary supplement, now had been reported to exhibit several 
therapeutic properties such as immune-stimulating and antiviral activities. It had been found to activate 
macrophages, NK cells, T-cells, B-cells, and to induce the production of interferon gamma and other 
cytokines (Khan et.al.,2005; Simpore et. al., 2005; Theodore, G., 2013). Natural substances isolated from S. 
platensis had been found to be effective inhibitors against several enveloped viruses by blocking viral 
absorption penetration and some replication stages of progeny viruses after penetration into cells (Weid, 
2000). 
3.3 Immunomodulatory and Anti-allergic 
Spirulina exhibits anti-inflammatory properties by preventing the release of histamine from mast cells 
(Chirasuwan et. al., 2007;2009). In a recent randomized, clinical, double-blind placebo-controlled trial 
(Cleaveland et. al., 2001), individuals diagnosed with allergic rhinitis were fed daily basis, either with placebo 
or Spirulina for 12 weeks. Samples of peripheral blood mononuclear cells were isolated before and after the 
Spirulina feeding and levels of cytokines (interleukin-4 (IL-4), interferon-γ (IFN-γ) and interleukin-2), which 
are important in regulating immunoglobulin (Ig)E-mediated allergy, were measured. The study reported 
that an optimum dose of Spirulina considerably reduced IL-4 levels by 32%, demonstrating the protective 
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effects of this microalga toward allergic rhinitis. Ishii et. al., (1999) studied the influence of Spirulina on 
immunoglobulins IgA levels in human saliva and confirmed that it enhances IgA production, suggesting a 
pivotal role of microalga in mucosal immunity. It is well understood and proven with many research studies 
that deficiency of nutrients is responsible for many significant changes in immunity, which establishes as 
changes in production of T-cells, secretory IgA antibody response, cytokines and NK-cell activity. The 
studies also suggest that nutritional properties Spirulina may modulate the immune system by covering 
nutritional deficiencies. 
3.4 Anti-Inflammatory 
Various research studies reported that free bilirubin functions physiologically as a potent inhibitor of 
NADPH oxidase activity. Similarly, phycocyanin (PC), a blue green pigment protein found in Spirulina, also 
reported to be a potent inhibitor of this enzyme complex. This protein has been observed to reduce rapidly 
in phycocyanorubin, in mammals which is a close homolog of bilirubin (Helliwell, 2011). Phycocyanin 
extracted from Spirulina can be administered orally as an anti-inflammatory agent. The easiest and most 
economical way to administer phycocyanin is intake of whole Spirulina in either in form of tablets or 
capsules. (McCarty, 2007). 
3.5 Antioxidant 
Antioxidants are compounds that help to fight cell and DNA damage that leads to cancer, heart disease and 
other chronic diseases. Some antioxidants are synthesised by body and others are present in form of 
different foods whose intake is through diet. C-phycocyanin (C-PC) is one of the most important 
biliproteins of Spirulina with antioxidant and free radical scavenging properties. C-PC, a selective 
cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages 
(Reddy, M.C., et.al.,2003). It is also known to have anti-inflammatory and anticancer properties (Hayashi 
K, et. al., 1993). Though, till date, there are no in vivo studies been done on human beings to understand 
the antioxidant effects of Spirulina. 
3.6 Hepatoprotective 
Spirulina has a great hepatoprotective potential due to its composition. The natural antioxidant compounds 
present in Spirulina like vitamins (E and C), minerals, phenolic compounds and some fatty acids may act 
individually or together provide protection and strengthen the liver functions (Garcia-Martinez et. al., 2007). 
Intraperitoneal administration of C-phycocyanin of Spirulina platensis was found successful in reduction of 
lipid peroxidation in the liver microsomes in CCl4-intoxicated rats (Bhat and Madyastha, 2000). Role of 
Spirulina in preventing the chronic hepatitis from being transformed to hepatic cirrhosis was well described 
by Gorban et. al., (2000). In histopathological studies, the efficacy of Spirulina fusiformis was found very 
promising. Upon administration of optimised dosages of Spirulina extracts regeneration of hepatocytes was 
reported. The hepatoprotective property of the extract may be attributed to the presence of various 
bioactive constituents which are present in Spirulina fusiformis (Mathew et. Al.,1995). To get a clear 
understanding on mechanism of action of Spirulina in liver protection extensive research is required 
(Sharma and Dunkwal, 2012). 
4 Conclusions 
Several research studies recommended that Spirulina can be a potential and ideal candidate for conjugative 
or alternate therapy against disease treatments due to possible synergetic effect of many bioactive 
compounds present in the whole cell. It has been demonstrated that the use of Spirulina and its extracts may 
significantly reduce cancer and viral diseases. Though, more research is needed to determine the usefulness 
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of Spirulina against COVID 19 like killer diseases. Scientists across the world and primarily in India, China, 
Japan, USA are studying this extraordinary superfood to unlock its full potential. However, it is pretty clear 
from published research and in vivo clinical studies that Spirulina is safe natural superfood to be consumed 
for ideal health and wellness. The multifunctional role of Spirulina components makes it an ideal natural 
remedy with massive prophylactic and therapeutic properties. 
“Let your food be your medicine”. Hippocrates 
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